BIOCRYST PHARMACEUTICALS INC — Director's Dealing 2015

May 22, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOCRYST PHARMACEUTICALS INC (BCRX)
CIK: 0000882796
Period of Report: 2015-05-20

Reporting Person: Cohen Fred E (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-05-20	Automatic Stock Option Grant	$11.39	A	15000	Acquired	2025-05-20	Common Stock (15000)	Direct

Footnotes

F1: Automatic non-employee director grant pursuant to the BioCryst Pharmaceuticals, Inc. Stock Incentive Plan.

F2: Vests 1/12th per month over twelve months beginning June 20, 2015.